Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prof Paul Newton, Head of the Medicine Quality Group at the Infectious Diseases Data Observatory (IDDO), explains the need for new strategies for tackling poor quality medical products.

Pills banner.jpg

The proliferation of poor quality medical products (medicines, vaccines and devices) is an important but neglected public health problem, threatening millions of people all over the world, both in developing and wealthy countries. A recent report from the World Health Organization found that an estimated 1 in 10 medicines in low- and middle-income countries were falsified or substandard. Falsified diazepam found across Scotland has been reported as being “cheaper than chips”.

Find out more (University of Oxford Science Blog)